Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Malone

Showing results (511-520 of 771) with videos related to

Pageof 78
Sort By:
Infection Prevention in Practice|September 6, 2021
Nosocomial or not? A combined epidemiological and genomic investigation to understand hospital-acquired COVID-19 infection on an elderly care wardR D Wenlock, M Tausan, R Mann, et al.
JMIR Medical Informatics|March 22, 2021
Applying Clinical Decision Support Design Best Practices With the Practical Robust Implementation and Sustainability Model Versus Reliance on Commercially Available Clinical Decision Support Tools: Randomized Controlled TrialKaty E Trinkley, Miranda E Kroehl, Michael G Kahn, et al.
Applied Clinical Informatics|October 18, 2023
Sustained Effect of Clinical Decision Support for Heart Failure: A Natural Experiment Using Implementation ScienceKaty E Trinkley, Garth Wright, Larry A Allen, et al.
Drug Safety|January 4, 2015
Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision supportRichard T Scheife, Lisa E Hines, Richard D Boyce, et al.
Neuro-Oncology|November 11, 2017
A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913Prakash Chinnaiyan, Minhee Won, Patrick Y Wen, et al.
Frontiers in Pharmacology|March 25, 2021
A Minimal Information Model for Potential Drug-Drug InteractionsHarry Hochheiser, Xia Jing, Elizabeth A Garcia, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 6, 2016
Recommendations for selecting drug-drug interactions for clinical decision supportHugh Tilson, Lisa E Hines, Gerald McEvoy, et al.
European Urology|January 29, 2023
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised TrialLoren K Mell, Stephanie L Pugh, Christopher U Jones, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|November 6, 2025
Mapping CMV-related immune signatures in blood, aorta and perivascular mediastinal adipose tissueCassia Labeb, Laventa M Obare, Quanhu Sheng, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415Maria Thor, Joseph O Deasy, Rebecca Paulus, et al.
Pageof 78

Showing results (511-520 of 771) with videos related to

Sort By:
Pageof 78
Infection Prevention in Practice|September 6, 2021
Nosocomial or not? A combined epidemiological and genomic investigation to understand hospital-acquired COVID-19 infection on an elderly care wardR D Wenlock, M Tausan, R Mann, et al.
JMIR Medical Informatics|March 22, 2021
Applying Clinical Decision Support Design Best Practices With the Practical Robust Implementation and Sustainability Model Versus Reliance on Commercially Available Clinical Decision Support Tools: Randomized Controlled TrialKaty E Trinkley, Miranda E Kroehl, Michael G Kahn, et al.
Applied Clinical Informatics|October 18, 2023
Sustained Effect of Clinical Decision Support for Heart Failure: A Natural Experiment Using Implementation ScienceKaty E Trinkley, Garth Wright, Larry A Allen, et al.
Drug Safety|January 4, 2015
Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision supportRichard T Scheife, Lisa E Hines, Richard D Boyce, et al.
Neuro-Oncology|November 11, 2017
A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913Prakash Chinnaiyan, Minhee Won, Patrick Y Wen, et al.
Frontiers in Pharmacology|March 25, 2021
A Minimal Information Model for Potential Drug-Drug InteractionsHarry Hochheiser, Xia Jing, Elizabeth A Garcia, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 6, 2016
Recommendations for selecting drug-drug interactions for clinical decision supportHugh Tilson, Lisa E Hines, Gerald McEvoy, et al.
European Urology|January 29, 2023
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised TrialLoren K Mell, Stephanie L Pugh, Christopher U Jones, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|November 6, 2025
Mapping CMV-related immune signatures in blood, aorta and perivascular mediastinal adipose tissueCassia Labeb, Laventa M Obare, Quanhu Sheng, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415Maria Thor, Joseph O Deasy, Rebecca Paulus, et al.
Pageof 78